Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2012
10/26/2012WO2012144613A1 Method for producing complex crystal and method for screening complex crystal
10/26/2012WO2012144592A1 Solid pharmaceutical composition
10/26/2012WO2012144579A1 Antibody preparation having solution form
10/26/2012WO2012144560A1 Self-gelatinizable nucleic acid
10/26/2012WO2012144519A1 Granules in liquid dosage form
10/26/2012WO2012144446A1 Drug delivery particles and method for producing same
10/26/2012WO2012144405A1 Method for producing adhesive patch, and adhesive patch
10/26/2012WO2012143876A1 A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
10/26/2012WO2012143875A1 Method of preparation of chitin and active principles complexes and the so obtained complexes
10/26/2012WO2012143868A1 Suspension type topical formulations comprising cyclic depsipeptide
10/26/2012WO2012143739A1 Sonodynamic therapy
10/26/2012WO2012143524A2 Bispecific antibodies against her2 and cd3
10/26/2012WO2012143499A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143497A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143496A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143495A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143486A1 Antigenic formulation
10/26/2012WO2012143418A1 STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc
10/26/2012WO2012143013A1 Improved wound care product
10/26/2012WO2012142669A1 A method for the treatment of a solid tumour
10/26/2012WO2012116357A3 Use of agr3 for treating cancer
10/26/2012WO2012112767A3 Collagen-targeted nanoparticles
10/26/2012WO2012111996A3 Transdermal delivery system containing galantamine or salts thereof
10/26/2012WO2012110636A3 Carrier peptides for cell delivery
10/26/2012WO2012109473A8 Detection of endotoxins
10/26/2012WO2012108631A3 Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
10/26/2012WO2012105794A3 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same
10/26/2012WO2012097049A3 Dna repair enzyme inhibitor nanoparticles and uses thereof
10/26/2012WO2012096926A3 Method for delivering agents into cells using bacterial toxins
10/26/2012WO2012094679A3 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
10/26/2012WO2012094620A3 Hydrophobic molecule-induced branched polymer aggregates and their use
10/26/2012WO2012094598A3 Pharmaceutical compositions of iron for oral administration
10/26/2012WO2012088306A3 Two-piece injectable drug delivery device with heat-cured seal
10/26/2012WO2012087823A3 Ph-induced silk fibroin gels and uses thereof
10/26/2012WO2012056387A3 A dermaceutical gel made using sodium fusidate and a process to make it
10/26/2012WO2012031250A8 Compositions for labeling nerves and methods of use
10/26/2012CA2833879A1 Compositions and methods for stabilization of active agents
10/26/2012CA2833690A1 Novel binder-drug conjugates (adcs) and their use
10/26/2012CA2833633A1 Composition and method for enhancing an immune response
10/26/2012CA2833596A1 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/26/2012CA2833594A1 Liquid carrier for oral delivery of a pharmacologically active agent
10/26/2012CA2833591A1 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/26/2012CA2833477A1 Novel binder-drug conjugates (adcs) and their use
10/26/2012CA2833474A1 Method for producing patch, and patch
10/26/2012CA2833427A1 Stable pharmaceutical liquid formulations of the fusion protein tnfr:fc
10/26/2012CA2833413A1 A method for the treatment of a solid tumour
10/26/2012CA2833369A1 Vaccine delivery method
10/26/2012CA2833326A1 Suspension type topical formulations comprising cyclic depsipeptide
10/26/2012CA2833223A1 New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1)
10/26/2012CA2832389A1 Bispecific antibodies against her2 and cd3
10/26/2012CA2831650A1 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
10/25/2012US20120271361 Functionalized Nanodiamond Reinforced Biopolymers
10/25/2012US20120271032 Preparation of a Therapeutic Composition
10/25/2012US20120270956 Use of protein satb2 as a marker for colorectal cancer
10/25/2012US20120270955 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120270933 Liquid statin formulation
10/25/2012US20120270927 Polyamides For Nucleic Acid Delivery
10/25/2012US20120270920 Compositions and methods for treatment of pouchitis
10/25/2012US20120270916 Topical formulations for treating neuropathy
10/25/2012US20120270909 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/25/2012US20120270822 Stabilized formulation for oral administration of therapeutic agents and related methods
10/25/2012US20120269908 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269888 Barrier composition
10/25/2012US20120269886 Therapeutic agent for pulmonary fibrosis
10/25/2012US20120269878 Composition For Transdermal Delivery Of Fentanyl
10/25/2012US20120269866 Gastroretentive Composition On The Basis Of A Water-Soluble Reaction Product From A Vinyl Group-Containing Precursor
10/25/2012US20120269862 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269792 Eutectic-based self-nanoemulsified drug delivery system
10/25/2012US20120269772 Lipid depot formulations
10/25/2012US20120269739 Composition, use, and preservation method
10/25/2012DE102011018499A1 Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut Topical nanoparticle vaccines for immune stimulation of the dendritic cells in the skin
10/24/2012EP2514760A1 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
10/24/2012EP2514757A2 Glycopegylated granulocyte colony stimulating factor
10/24/2012EP2514441A1 Passive solid tumor targeting anticancer prodrug and preparation method thereof
10/24/2012EP2514440A1 Transdermal preparation containing basic anti-inflammatory agent
10/24/2012EP2514422A1 Elution-stabilized preparation
10/24/2012EP2514416A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514415A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514414A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514412A1 Highly Concentrated Insulin Solutions and Compositions
10/24/2012EP2514410A2 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine
10/24/2012EP2514409A1 Topical pharmaceutical compositions of nimesulide and methylsulfonylmethane
10/24/2012EP2514407A1 Stable non-aqueous pharmaceutical compositions
10/24/2012EP2514406A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
10/24/2012EP2514321A1 Liquid food composition
10/24/2012EP2513299A1 Decellularized adipose tissue
10/24/2012EP2513294A1 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof
10/24/2012EP2513225A1 Local delivery of drugs from self assembled coatings
10/24/2012EP2513141A2 Glp-1 analogues and derivatives
10/24/2012EP2513140A1 Double-acylated glp-1 derivatives
10/24/2012EP2513083A1 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
10/24/2012EP2512522A2 Particles for multiple agent delivery
10/24/2012EP2512521A2 Dendritic high-molecular-weight polymer drug carriers and their conjugates with drugs especially for treatment of solid tumours
10/24/2012EP2512520A1 Polyethylene glycol containing composition for shaving
10/24/2012EP2512519A2 Clostridium botulinum carrier complex for the administration of therapeutic agents
10/24/2012EP2512518A1 Glp-1 receptor agonist compounds with a modified n-terminus
10/24/2012EP2512517A2 Hyperbranched polyester having a hydrophobic core for solubilizing active ingredients of low solubility
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1712